Torulaspora delbrueckii

Other Names

Candida colliculosaDebaryomyces dekkeriDebaryomyces delbrueckiiDebaryomyces nilssoniSaccharomyces chevalieri var. torulosusSaccharomyces delbrueckiiSaccharomyces delbrueckii var. mongolicusSaccharomyces fermentatiSaccharomyces roseiSaccharomyces roseusSchwanniomyces hominisTorulaspora fermentatiTorulaspora mongolicaTorulaspora roseiTorulopsis combresieriTorulopsis stellata var. cambresieriZygosaccharomyces globiformisZygosaccharomyces globiformis f. coronataZygosaccharomyces globiformis f. typicaZymodebaryomyces dekkeri

Synopsis

Identity: Taxonomy, Nomenclature, and Natural Sources

Taxonomic Classification and Synonyms

Torulaspora delbrueckii belongs to the phylum Ascomycota, subphylum Saccharomycotina, class Saccharomycetes, order Saccharomycetales, family Saccharomycetaceae. It is the type species of the genus Torulaspora and is one of the most thoroughly studied non-Saccharomyces yeast species in the context of food biotechnology and, more recently, dietary supplementation.

The genus Torulaspora includes at least six species: T. delbrueckii (anamorph Candida colliculosa), T. franciscae, T. pretoriensis, T. microellipsoides, T. globosa, and T. maleeae. Other species have also been proposed for inclusion in this genus following their characterisation by molecular tools, and the taxonomy of Torulaspora is changing rapidly, with species reassignments and new species expected in the near future.

Torulaspora delbrueckii has a very long list of synonyms which include a lot of different genera like Saccharomyces, Debaryomyces, Zygosaccharomyces, and Torulaspora. In 1970, Kurtzman et al. assigned Torulaspora and Zygosaccharomyces to Saccharomyces, leaving Debaryomyces as a separate species; five years later, van der Walt and Johannsen recreated the genus Torulaspora and incorporated all Debaryomyces species to it as well. This taxonomic instability is not uncommon in yeast taxonomy, because Saccharomyces, Debaryomyces, Zygosaccharomyces, and Torulaspora share biochemical and phenotypical similarities that make differentiation of species difficult.

The valid type strain of T. delbrueckii is CBS 1146T, equivalent to CLIB 230 or ATCC 10662.

Natural Habitat and Ecological Sources

Torulaspora delbrueckii colonizes several natural environments, ranging from soils, to plants, fruits, and insects. T. delbrueckii is widely distributed in nature and has been isolated from soil, fermenting grapes and other berry juices, agave juice, tea-beer, and tree bark. The genus is mostly known from its type species, T. delbrueckii, a frequent colonizer of wine and sourdough bread fermentations.

Torulaspora are fermentative yeasts that can be found in wild and anthropic habitats, where they may coincide with other fermentative yeasts such as Saccharomyces and Zygosaccharomyces. The genus currently contains species that are typically found in various natural terrestrial environments in temperate and tropical climates.

Common Commercial Forms and Preparations

Torulaspora delbrueckii is isolated from several human bioprocesses, including the bread industry where some T. delbrueckii strains are commercialized for frozen dough applications. Other applications include food fermentations of silage, cocoa, olive, or cucumber; distilled and traditional fermented beverage production including mescal, colonche, tequila, cider, strawberry tree fruits juice, sugarcane juice, or kefir; and dairy products' fermentations like traditional cheeses and fermented milk.

Freeze-dried yeast strains of T. delbrueckii have been shown to achieve survival rates between 76.62% and 93.38%, and physiological characterization confirms interesting attributes including carbon assimilation, ethanol tolerance, acetic acid and H₂S production, temperature and low pH tolerance, enzymatic pattern, and killer phenotype. When prepared as dietary supplements, the yeast is most commonly encountered in freeze-dried or lyophilized form, which preserves cell viability for use as a functional food ingredient or probiotic candidate.

Traditional and Historical Use

Deep Antiquity in Fermented Foods

Torulaspora delbrueckii (anamorph Candida colliculosa) is a species whose use supposedly dates back over 4,000 years, and it is well studied today in wine controlled fermentation processes because of its good production of fruity flavors. Recent findings show that the T. delbrueckii species has been domesticated for winemaking and other human uses approximately 1,900 and 4,000 years ago, respectively.

Baking and brewing are among the oldest bioprocesses refined by human societies, and both fermentative processes have successfully used domesticated strains of Saccharomyces cerevisiae as a biocatalyst throughout their evolution. T. delbrueckii was a co-inhabitant of these traditional fermentation environments long before it was formally recognized as a distinct species. Sourdough has been used since ancient times as a biotechnological strategy for the fermentation of cereals, and among yeasts, Saccharomyces cerevisiae, Kazachstania exigua, Kazachstania humilis, Torulaspora delbrueckii, Wickerhamomyces anomalus, and Pichia kudriavzevii commonly dominate the fungal community.

Role in Traditional Regional Beverages and Foods

Torulaspora delbrueckii has been associated with winemaking for decades and isolated either from grape, must, or wine, and is now proposed as a starter culture to be associated with S. cerevisiae in mixed cultures for certain applications, particularly to reduce volatile acidity in high-sugar fermentations like Sauternes wines.

Some authors assume that T. delbrueckii is also one of the main organisms responsible for the fermentation of Bavarian wheat beers. The yeast has also been documented as a natural component of kefir microbiota—a fermented dairy beverage with roots in the Caucasus region—as well as in the traditional production of mescal and tequila in Mexico and colonche, a traditional Mexican fermented beverage from prickly pear cactus fruit.

The strain PYCC5323 of Torulaspora delbrueckii, isolated from traditional corn and rye bread dough from the North of Portugal, displays high freeze and osmotic tolerance besides presenting dough-raising capacity, growth rates, and biomass yields similar to commercial baker's yeast.

In Italy, Torulaspora delbrueckii, Pichia kluyveri, Candida boidinii, and Candida diddensiae were detected as members of the microbial consortium in traditional Sicilian sourdough. Although functional and nutritional features of sourdough have been traditionally attributed to the lactic acid bacteria (LAB) metabolism, several studies have highlighted a link with the activities of the yeast population, including the ability to produce vitamins, to exert phytase and antioxidant activities, as well as probiotic properties.

Key Constituents and Active Compounds

Cell Wall Components: Mannoproteins and β-Glucans

Mannoproteins (MPs) are proteoglycans from the outermost layer of yeast cell walls released into the medium during alcoholic fermentation and ageing on lees processes. Research has specifically investigated T. delbrueckii as a novel source of these compounds. Mannose predominates in mannoprotein extracts from T. delbrueckii, and a higher content of glucose is observed in certain enzymatic extracts, suggesting the release of portions of cell wall β-glucan or fragments composed of a mannoprotein connected to a portion of β-glucan through enzymatic treatment.

Both Saccharomyces cerevisiae and Torulaspora delbrueckii have been used as starting microorganisms for the production of yeast derivatives using emerging technologies, with glutathione content measured at approximately 7.2 µmol/g in T. delbrueckii-derived enzymatic preparations. Protein-related amino acids like tyrosine, methionine, histidine, lysine, and tryptophan have been shown to exhibit antioxidant activity due to their propensity to transfer protons to electron-deficient radicals, and the presence of carboxyl groups in mannan polysaccharides can also explain their free radical quenching capacity.

Trehalose and Stress-Response Metabolites

Torulaspora delbrueckii strains under hyperosmotic and frozen stresses in sweet dough have shown the ability to adapt promptly to high-osmotic-pressure environments, which correlates in part with a low-invertase activity, as well as a slow rate of trehalose mobilisation, displaying a higher accumulation of trehalose. Both trehalose and glycogen are known as major stores of glucose in yeast cells. A rapid increase of the levels of these sugars is an early metabolic response during conditions of oxidative, heat, or salt/osmotic stresses, and these sugars are proposed to have several physiological functions, including acting as glycolytic safety valves.

In T. delbrueckii strain PYCC5323, no loss of cell viability was observed for at least 120 days during freezing at −20°C, whereas a loss of 80% was observed in commercial baker's yeast after 15 days. This freeze resistance was dependent on an adaptation process, and the primary cell target of freeze stress was the plasma membrane, with preservation of its integrity related to a lower increase of lipid peroxidation and a higher resistance to H₂O₂, but not with intracellular trehalose concentration.

Tryptophan-Derived Metabolites

Yeast metabolism significantly contributes to functional beverage production by generating bioactive compounds such as tryptophan derivatives (dTRPs), and non-Saccharomyces yeasts like Torulaspora delbrueckii are gaining interest for their ability to enhance aroma profiles and influence metabolite synthesis. A study evaluating dTRP production of T. delbrueckii CBS1146T in synthetic medium and Cabernet Sauvignon must supplemented with tryptophan found, via LC-MS/MS analysis, strain-dependent differences in metabolite profiles, with a predominance of kynurenine pathway compounds and the first identification of two tryptophan-ethylester (TEE) isomers. T. delbrueckii exhibited significant TEE production, correlating with the consumption of dTRPs. Notably, melatonin was not detected in T. delbrueckii in this study, a finding relevant to claims made in some commercial contexts about yeast-derived melatonin.

Aromatic and Fermentation Metabolites

This yeast has been reported to improve wine parameters, including decreased acetic acid and ethanol production, increased amounts of glycerol, increased mannoprotein and polysaccharide release, promotion of malolactic fermentation, increased amounts of wanted aromatic compounds (fruity esters, lactones, thiols, and terpenes), and decreased amounts of unwanted aromatic compounds such as higher alcohols.

Beer fermented with T. delbrueckii MI120 has been shown to have the highest phenolic content (96.02 μg GAE·mL⁻¹) and antioxidant activity (90.43%), matching commercial Saccharomyces cerevisiae in sensory traits such as taste and aroma.

Killer Toxins

Some strains of T. delbrueckii produce killer toxins encoded by double-stranded RNA viruses. These strains kill all previously known Saccharomyces cerevisiae killer strains, in addition to other non-Saccharomyces yeasts. The Kbarr-1 phenotype is encoded by a medium-size 1.7 kb dsRNA, TdV-Mbarr-1, which seems to depend on a large-size 4.6 kb dsRNA virus (TdV-LAbarr) for stable maintenance and replication. These killer toxins have potential relevance to biocontrol of pathogens and competing microorganisms during fermentation.

Mechanisms of Action

Membrane Integrity and Freeze Tolerance

In the baking industry, T. delbrueckii is recognized as a superior choice due to its importance in the production of frozen dough products, since it exhibits a very good baking ability and a high capacity to resist osmotic and freeze-thaw stresses, while S. cerevisiae, the most commonly used yeast in the baking industry, loses viability fast under the same conditions. This feature of T. delbrueckii is presumably related to its improved capacity to preserve its membrane integrity.

Osmotic Stress Adaptation

T. delbrueckii displays higher leavening ability than S. cerevisiae under conditions of hyperosmotic stress in bread dough containing 20% sucrose and 2% salt. This feature is in agreement with a low invertase activity, a slow rate of trehalose mobilisation, and the ability to respond rapidly to osmotic stress.

Antimicrobial and Biocontrol Activity

T. delbrueckii has attracted renewed interest for its biotechnological potential linked to its ability to enhance the flavor and aroma complexity of wine, and sequential fermentations with selected native strains of T. delbrueckii have been studied in combination with Saccharomyces cerevisiae. Native T. delbrueckii showed a biocontrol action in the first two days of fermentation, with wild yeasts reduced by approximately 1 log at the second day.

Some Torulaspora strains exhibit antibacterial and antifungal activity against Candida albicans, Escherichia coli, Staphylococcus aureus, and Salmonella enterica.

Probiotic Mechanisms: Gut Barrier and Microbiota Modulation

Early research suggests that Torulaspora strains, particularly T. delbrueckii, have potential as a probiotic, showing benefits like improving gut barrier function and modulating the immune system. Studies suggest that T. delbrueckii may promote the growth of beneficial bacteria and inhibit harmful ones, leading to better digestion, reduced inflammation, and a stronger immune system. These proposed mechanisms remain at the early or preclinical stage and have not yet been confirmed in rigorous human clinical trials.

Scientific Evidence by Area of Use

Probiotic Properties and Gut Health

Evidence Grade: Preliminary — animal and in vitro data only; no published human clinical trials identified.

A 2024 study published in Nutrire used T. delbrueckii as a prospective probiotic along with bananas as a prebiotic to investigate potential roles in modulating lipid content and bacterial populations in the feces of rats. A yeast strain was isolated from milk and identified using conventional and molecular tools as T. delbrueckii, which showed promising results upon testing for acid and bile tolerance, and had the capacity to thrive in simulated stomach and intestinal fluids.

In this animal feeding experiment, rats fed T. delbrueckii developed and acquired mass in a regular manner. Consuming T. delbrueckii also dramatically lowered LDL, cholesterol, and triglyceride levels while dramatically raising HDL levels. Consuming both T. delbrueckii and bananas along with the regular animal diet considerably reduced the amount of coliforms and Staphylococcus sp. These findings are from an animal model and must be considered preliminary; no human data currently replicate these lipid-modulating effects.

A study evaluating the ability to survive under simulated gastrointestinal conditions found that Torulaspora delbrueckii B14 and Kluyveromyces lactis B10 are interesting yeasts for further studies in the context of probiotics and positively impact the composition of desirable volatile compounds in cheeses, particularly when used as mixed inoculum.

Early research suggests that Torulaspora strains, particularly T. delbrueckii, have potential as a probiotic showing benefits like improving gut barrier function and modulating the immune system, and studies suggest that T. delbrueckii may promote the growth of beneficial bacteria. However, even if very little is known about its specific effects on gut health in humans, these findings from in vitro and animal models warrant further clinical investigation.

Gastrointestinal Survival and Probiotic Viability Testing

Evidence Grade: In vitro only; no human pharmacokinetic or colonization data available.

Yeast probiotic potential is commonly assessed through in vitro standardized tests, examining species identification, gastrointestinal survival (body temperature, low pH, digestive enzymes, and bile salts), adhesion to gut epithelial cells, antibiotic resistance, pathogen suppression, and non-pathogenicity.

In one study, all tested strains including T. delbrueckii survived well in simulated gastrointestinal conditions and had strong antioxidant activity (>68%), with no strain displaying hemolytic behavior. Freeze-dried yeast strains achieved survival rates between 76.62% and 93.38%. Following three hours of incubation under simulated gastric conditions, all the yeast strains showed a high tolerance, with survival rates ranging from 80.48% to 98.20%.

Members of the Saccharomyces, Kluyveromyces, Candida, Rhodotorula, Pichia, Meyerozyma, Torulaspora, Debaryomyces, and Yarrowia genera are common potential probiotic yeasts that have been isolated from different sources; however, currently, Saccharomyces cerevisiae is the only commercialized yeast that has been recognized as probiotic for humans.

Antioxidant Activity

Evidence Grade: In vitro; limited fermentation-model data.

T. delbrueckii may provide antioxidant activity in fermented products, and it has been reported to provide wines with flower and sweet aroma, a reduced astringency, and higher roundness by degrading in part malic acid and releasing membrane polysaccharides. Beer fermented with T. delbrueckii MI120 had the highest phenolic content (96.02 μg GAE·mL⁻¹) and antioxidant activity (90.43%), matching commercial Sacch. cerevisiae US-05 in sensory traits such as taste and aroma. These antioxidant findings are associated with fermented food matrices and do not translate directly to supplemental use in humans.

Lipid Metabolism (Cholesterol and Triglycerides)

Evidence Grade: Animal model only; no human data available.

Both T. delbrueckii as a prospective probiotic and bananas as a prebiotic were used to investigate potential roles in modulating lipid content in the feces of examined rats. According to the animal feeding experiment, rats fed T. delbrueckii developed and acquired mass in a regular manner, and consuming T. delbrueckii was associated with lower LDL, cholesterol, and triglyceride levels and raised HDL levels. The mechanism proposed relates to microbiota modulation, though it has not been confirmed in human subjects.

Functional Fermented Food Production (Wine, Beer, Bread)

Evidence Grade: Robust — multiple fermentation studies; well-characterized at biotechnological level.

Torulaspora delbrueckii is gaining relevance within the wine industry, owing to its low volatile acidity production, increased release of aromatic compounds, and enhanced color intensity. In addition, this yeast was also attracting interest in other biotechnological areas, such as bread and beer fermentation.

In the brewing industry, T. delbrueckii has been studied in depth, showing relevant characteristics in beer fermentation, such as osmotolerance, resistance to weak acids such as hop iso-α-acids, and a low contribution of undesirable compounds such as volatile phenols, acetic acid, and acetaldehyde.

In mezcal fermentations, a mixed inoculum of S. cerevisiae and T. delbrueckii has been used to obtain a balanced aromatic and fermentative profile. In cider production, monoculture fermentations using T. delbrueckii strains showed production of more diverse volatile compounds than with S. cerevisiae strains.

Tryptophan Metabolite Production

Evidence Grade: In vitro analytical chemistry; no health outcome data in humans.

A study evaluating dTRP production of T. delbrueckii CBS1146T and Z. bailii ATCC36947T in synthetic medium and Cabernet Sauvignon must supplemented with 100 mg/L tryptophan found via LC-MS/MS analysis a predominance of kynurenine pathway compounds and the first identification of two tryptophan-ethylester (TEE) isomers. T. delbrueckii exhibited significant TEE production, correlating with the consumption of dTRPs. The potential of yeast metabolites in functional beverage production is confirmed by the presence of biochemical pathways for the synthesis of useful molecules derived from tryptophan, such as melatonin and serotonin (5-OH TRY). Tryptophan (TRP) is a non-polar, aromatic amino acid containing an indole ring that, after absorption, can be converted into bioactive compounds each able to influence metabolic pathways and physiological responses. Whether T. delbrueckii fermentation meaningfully contributes to biologically relevant concentrations of these metabolites in humans remains to be established.

Body Systems and Health Areas of Association

Gastrointestinal System: Research suggests that specific yeast strains possess properties that could be beneficial for managing conditions like inflammatory bowel disease, irritable bowel syndrome, skin disorders, and allergies. For T. delbrueckii specifically, evidence is limited to in vitro acid/bile tolerance testing and rat studies. No human clinical trials have been completed or published.
Immune System: T. delbrueckii has potential as a probiotic showing benefits like improving gut barrier function and modulating the immune system, based on early research. Evidence remains preclinical.
Lipid and Cardiovascular Metabolism: Consuming T. delbrueckii was associated in a rat model with dramatically lower LDL, cholesterol, and triglyceride levels and raised HDL levels. These effects have not been studied in human trials.
Antimicrobial and Gut Microbiota: Consuming both T. delbrueckii and bananas along with a regular diet considerably reduced the amount of coliforms and Staphylococcus sp. in rat fecal samples. Human microbiota modulation data are absent.
Antioxidant Defense: Preclinical data from fermented food matrices and in vitro studies indicate the yeast generates phenolic compounds and glutathione, and fermented products containing T. delbrueckii have measurable antioxidant activity, though human bioavailability has not been characterized.

Dosage Forms and Dosages Reported in Studies

Because T. delbrueckii is not currently approved or widely sold as a standardized human dietary supplement, formal dosage guidelines from regulatory bodies (such as the NIH ODS or EFSA) do not exist for this species. The dosage information available in the peer-reviewed literature derives primarily from in vitro and animal studies.

Animal model (rat) probiotic study: In the 2024 Nutrire study, T. delbrueckii isolated from milk was administered to rats as a prospective probiotic in combination with bananas as a prebiotic, with the experimental design investigating modulation of lipid content and fecal bacterial numbers. The specific dose in CFU or grams per kilogram body weight was not detailed in the available abstract.
Freeze-dried preparations (viability testing): Freeze-dried yeast strains of T. delbrueckii achieved survival rates between 76.62% and 93.38% in viability testing, demonstrating suitability for dried formulations.
Simulated gastrointestinal testing: Following three hours of incubation under simulated gastric conditions, T. delbrueckii strains showed survival rates ranging from 80.48% to 98.20%.
Fermentation matrices: T. delbrueckii MI120 beer fermentations yielded a phenolic content of 96.02 μg GAE·mL⁻¹ and antioxidant activity of 90.43%.
Tryptophan metabolite study: The dTRP production study supplemented fermentation medium with 100 mg/L tryptophan to evaluate metabolite output by T. delbrueckii CBS1146T.

No human clinical dosing regimens have been published for T. delbrueckii as a standalone dietary supplement as of the available peer-reviewed literature.

Safety Considerations

General Safety Profile

T. delbrueckii is occasionally found as a clinical isolate, although it is not considered to be a human pathogen; this state is described as opportunistic pathogen. This distinction is important: the yeast has been consumed by humans in fermented foods for millennia without documented adverse effects in immunocompetent individuals, but its status as an "opportunistic" organism warrants attention in clinical contexts.

Currently, Saccharomyces cerevisiae is the only commercialized yeast that has been recognized as being probiotic for humans. T. delbrueckii has not yet received a formal probiotic status from any major regulatory body (FDA, EFSA, or equivalent), nor has it been assigned a Qualified Presumption of Safety (QPS) designation by EFSA specifically for supplement use.

Opportunistic Pathogen Classification

Torulaspora delbrueckii can be an opportunistic spoilage yeast for dairy products or soft drinks, and it colonizes several natural environments ranging from soils, to plants, fruits, and insects. T. delbrueckii is occasionally found as a clinical isolate, though not considered to be a human pathogen — a state described as opportunistic pathogen. The significance of this designation in the context of healthy individuals consuming the yeast as a food ingredient or supplement is currently unclear, but the potential risk to immunocompromised individuals has not been formally evaluated in dedicated clinical safety studies.

Hemolytic Activity

No strain in the tested panel, which included T. delbrueckii, displayed hemolytic behavior in in vitro safety screening. Non-hemolytic status is a standard safety criterion for probiotic candidates.

Stress Tolerance and Industrial Survival

T. delbrueckii growth is significantly affected by high temperature (37°C) and ethanol concentrations (up to 18%), alongside 1.5 mM SO₂, showing variable fermentative power and yields. Growth at human body temperature (37°C) is impaired compared to lower fermentation temperatures, which may limit proliferation in vivo, though this has not been tested in human subjects.

Antibiotic Resistance Profile

In one probiotic characterization study, S. bacillaris and Sacch. cerevisiae resisted all tested antibiotics, while no strain displayed hemolytic behavior. The antibiotic resistance profile of T. delbrueckii in the context of supplemental use has not been fully characterized in independent human safety studies.

Absence of Human Clinical Safety Trials

The available published literature does not include completed, peer-reviewed randomized controlled trials assessing the safety, tolerability, or adverse effect profile of T. delbrueckii as an oral dietary supplement in humans. The evidence base is limited to in vitro screening, rat model studies, and observations from long-standing human consumption in fermented food contexts.

Summary of Evidence Strength

Biotechnological characterization (wine, beer, bread): Strong; multiple independent peer-reviewed studies across numerous research groups worldwide.
In vitro probiotic screening (acid/bile tolerance, antioxidant, antimicrobial): Moderate for the specific parameters tested; replicable in laboratory conditions but does not establish human health effects.
Animal model data (lipid metabolism, gut microbiota modulation): Preliminary; a small number of rodent studies with encouraging but not definitive results.
Human clinical evidence: Absent for supplemental use. No peer-reviewed randomized controlled trials in humans have been published as of the available literature.

References

Health Conditions

Health conditions that Torulaspora delbrueckii may help support.

No conditions available.

Body Systems

Body systems that Torulaspora delbrueckii may help support.

No body systems available.